Cognitive Enhancement

DNSP-11

Dopamine Neuron Stimulating Peptide-11

GDNF-derived peptide targeting Parkinson's disease

DNSP-11 is an 11-amino-acid peptide derived from the proprotein region of GDNF (Glial Cell Line-Derived Neurotrophic Factor), developed as a potential treatment for Parkinson's disease.

DNS

Admin routes

Intranasal, Intracerebroventricular (research)

Popularity

Niche

Side effects

Generally mild

Vendors

0 rated

Key benefits

1Preserves dopaminergic neurons in Parkinson's disease models
2Small enough for potential intranasal delivery to the brain
3Distinct mechanism from full-length GDNF

What to expect

1
N/A

No human dosing data. Animal studies showed neuroprotection over 2-4 weeks.

Based on community reports and published research. Individual results vary significantly.

Dosing protocols

Research reference (animal studies)

Dose

Varies by study

Frequency

Daily in published protocols

Duration

2-4 weeks in animal studies

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Research status|Preclinical - animal models of Parkinson's disease

Overview

DNSP-11 was discovered by researchers at the University of Kentucky who identified that the pro-region of GDNF (the part normally cleaved off during processing) contains biologically active sequences. DNSP-11 specifically promotes the survival and function of dopaminergic neurons without requiring the full GDNF protein, which is too large to cross the blood-brain barrier easily. In animal models of Parkinson's disease, DNSP-11 preserved dopamine neuron function and improved motor outcomes. Its small size makes it a more practical therapeutic candidate than full-length GDNF.

How it works

DNSP-11 promotes dopaminergic neuron survival through mechanisms distinct from mature GDNF. While GDNF signals through the GFRalpha1/RET receptor complex, DNSP-11 appears to work through a different pathway. It increases dopamine levels, preserves tyrosine hydroxylase-positive neurons, and reduces oxidative stress in the substantia nigra. The exact receptor target is still being characterised.

Side effects

No human safety data available
moderateRare

Research history

2010

Bradley et al. publish identification and characterisation of DNSP-11

Recommended products

Hand-picked for this compound. Ships via Amazon πŸ‡ΊπŸ‡Έ

Affiliate links β€” small commission at no extra cost to you.All essentials β†’

References

  1. [1]Bradley LH, et al. 'Dopamine neuron stimulating actions of a GDNF propeptide.' PLoS ONE, 2010.

Frequently asked questions

Related peptides

Community experiences

Share your experience with DNSP-11. Effects, side effects, protocol details - help others make informed decisions.

Write a review

Rating:

No community reviews yet. Be the first to share your experience with DNSP-11.

Need to calculate your dose?

Use our free reconstitution calculator to work out syringe units for DNSP-11.

Open Calculator

Found this useful?

Share this guide

Get the free Beginner Peptide Protocol

Which peptides to start with, what to avoid, and safe handling. Delivered to your inbox.

Disclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Check your local regulations regarding peptide purchase and use.